Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)
NCT00765518
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Dilated Cardiomyopathy
Interventions
BIOLOGICAL:
Ixmyelocel-T
OTHER:
Standard of Care
Sponsor
Vericel Corporation